Baseline total metabolic tumor volume assessed by 18FDG-PET/CT predicts outcome in advanced melanoma patients treated with pembrolizumab

Activity: Talk or presentationTalk or presentation at a conference

Description

Poster Presentation - 21P
Period14 Dec 2018
Event titleESMO Immuno-Oncology Congress 2018
Event typeConference
LocationGeneva, Switzerland
Degree of RecognitionInternational